Industry

Reducing preparation steps to help support patient safety LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist® ready-to-administer prefilled syringes. Fresenius Kabi Simplist Glycopyrrolate Injection, USP is the most recent manufacturer-prepared product available in the company’s proprietary, ready-to-administer portfolio of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Viral Vector & Plasmid DNA Manufacturing Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Viral Vector & Plasmid DNA Manufacturing Market is projected to reach USD 3,296.84 million by 2027 from USD 860.08 million in 2021, at a CAGR 25.10% during the forecast period. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Contract Manufacturing Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Contract Manufacturing Market is projected to reach USD 157,658.35 million by 2027 from USD 97,178.18 million in 2021, at a CAGR 8.39% during the forecast period. Market Statistics: The report provides market … [Read more…]

– The handbook presents information for each life stage of Type 1 galactosemia, with the aim of guiding patients and caregivers from newborn diagnosis through adulthood to help understand the disease lexicon, build a care team and educate their support network on the disease – Created by the Galactosemia Foundation and made possible through support … [Read more…]

Adam Feldman, Pedro Santos and Will Sloss all joined VHP as Pre-MBA Associates in 2018 LOS ANGELES & STAMFORD, Conn.–(BUSINESS WIRE)–Varsity Healthcare Partners (“VHP”), a leading lower middle market healthcare services private equity investment firm, today announced the promotion of Adam Feldman, Pedro Santos and Will Sloss to Vice President from Senior Associate. In this … [Read more…]

The Apthera extended depth of focus IOL uses proprietary small aperture technology to filter out peripheral defocused light, allowing only focused light to reach the retina. Results from the U.S. pivotal trial showed Apthera IOL subjects achieved statistically superior uncorrected intermediate and near vision, and equivalent distance vision and contrast sensitivity compared to control subjects. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The global peptide therapeutics market is expected to record a value of US$44.43 billion in 2026, progressing at a CAGR of 6.95%, over the … [Read more…]

Extensive market guide, funded by Pivotal Ventures, unpacks the investment potential for investors and startups for tech-enabled solutions REDWOOD CITY, Calif.–(BUSINESS WIRE)–An exclusive report from Telosity by Vinaj Ventures reveals a record-breaking market demand for tech-enabled, mental health solutions to help combat rising rates of youth anxiety, depression and suicide. Providing extensive industry research and … [Read more…]

IRVING, Texas–(BUSINESS WIRE)–The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter. The dividend will be payable on October 3, 2022, to stockholders of record on September 1, 2022. “This dividend … [Read more…]

 Tarek Hassan, MD: Past President of American Society of Retina Specialists and Retina World Congress; Clinical researcher: global randomized clinical trials (>150), peer-reviewed (230); founder 6 medical device and/or medical education companies; holder of numerous issued patents and inventions CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, Inc. a private biotechnology company located in Cambridge MA with a proprietary … [Read more…]